« Projekte
GRIP-Studie
Finanzierung:
Industrie;
Prospective non-randomized (pharmacoepidemiologic) cohort study (open-label, multicenter) to assess the magnitude of potential risk with the administration of Gadovist in patients with moderate to severe renal impairment for the development of nephrogenic systemic fibrosis (NSF) based on diagnostically specific clinical and histopathologic information

Schlagworte

NSF
Kontakt

weitere Projekte

Die Daten werden geladen ...